title: [Maternal blood group 0 as a risk factor of neonatal hyperbilirubinemia requiring treatment].
abstract: The present prospective study indicates that children of mothers with blood group O run a double risk of hyperbilirubinemia requiring treatment as compared to children of mothers of blood group A, and 5-10 times increased risk of needing exchange transfusion. The most frequent cause of need for exchange transfusion was ABO-incompatibility between mother and child. A positive direct antiglobulin reaction in an ABO-incompatible child in need of treatment doubles the risk of exchange transfusion being required. Blood group O in the mother should be considered to be an independent risk factor for the child, and O-pregnant women should be ABO-grouped for this reason.
authors.affiliation: Blodbank og immunologisk avdeling, Ullevål sykehus, Oslo.
authors.forename: H E
authors.initials: HE
authors.lastname: Heier
authors.forename: D
authors.initials: D
authors.lastname: Fugelseth
authors.forename: R
authors.initials: R
authors.lastname: Lindemann
authors.forename: E
authors.initials: E
authors.lastname: Qvigstad
mesh_terms: D000017:ABO Blood-Group System; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000209:etiology* / Q000628:therapy; D011247:Pregnancy; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000017:ABO Blood-Group System
vernacular_title: Blodtype O hos mor som risikofaktor for behandlingstrengende hyperbilirubinemi hos nyfødte.